3756-C PATIENTS WITH HEPATITIS B AND D ARE MORE OFTEN LINKED TO MEDICAL CARE THAN PATIENTS WITH HEPATITIS C Elena Vargas-Accarino 1 , Anna Feliu-Prius 2 , Adriana Palom 1 , Ariadna Rando 1 , Ana Barreira 1 , Joan Martnez Camprecios 3 , Judit Vico-Romero 1 , Juan Carlos Ruiz Cobo 3 , Jordi Llaneras 3 , Mar Riveiro 3 , Francisco Rodriguez-Frias 1 , Rafael Esteban-Mur 4 and Maria Buti 5 , (1)Vall D'hebron Research Institute (VHIR), (2)Hospital Universitari Vall D'hebron, (3)Vall D'hebron Universitary Hospital, (4)Hospital Universitario Vall D'hebron, (5)Hospital Universitari Vall dHebron, Department of Medicine of the UAB (Universitat Autnoma de Barcelona), Spain Background: To achieve the WHO goals for viral hepatitis elimination is crucial to identify people living with hepatitis B and C
We were frustrated with the gap between what supplements claimed and what they actually contained
Improvement in the water solubility of drugs with a solid dispersion system by spray drying and hot-melt extrusion with using the amphiphilic Polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer and d -mannitol
A possible explanation for this absence of beneficial effects could be its low oral bioavailability or its complex intestinal absorption
